Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2026 08:06 ET | Source: Science 37, Inc.

Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families

Science 37 launches its dedicated Pediatrics Department, reinforcing the company’s commitment to advancing pediatric research.
March 17, 2026 06:30 ET | Source: Avance Clinical

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs
March 17, 2026 04:00 ET | Source: Mestag Therapeutics

Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic

Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic
March 16, 2026 07:30 ET | Source: Annovis Bio Inc.

Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

MALVERN, Pa., March 16, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
March 12, 2026 08:45 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Targets $3B+ Pancreatic Cancer Market with PRP: 85%+ Tumor Inhibition in Breakthrough Proenzyme Therapy

Conventional chemo hits walls of resistance, brutal toxicity, and minimal progress. PRP changes the game.
March 11, 2026 09:10 ET | Source: Radicle Science

‘Immensely World-Positive’: Former TED Owner Chris Anderson Invests in Radicle Science to Power the Future of Proven Precision Wellness

Radicle Science secures multimillion-dollar investment from Resilience Reserve and joins top accelerators to scale its AI-driven clinical evidence platform
March 10, 2026 10:00 ET | Source: Medidata Solutions, Inc.

AI Takes Center Stage at NEXT New York: Medidata Showcases AI Companions and Orchestrated Intelligence Transforming Life Sciences

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and global leader in clinical trial solutions, today unveiled a transformative vision for the life sciences industry at...
March 09, 2026 09:00 ET | Source: Medidata Solutions, Inc.

Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a strategic...
March 04, 2026 08:00 ET | Source: Medidata Solutions, Inc.

Medidata and CRIO Empower Over 2,500 Global Research Sites with Seamless Integration to Accelerate Clinical Trials

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has announced a partnership with...
March 03, 2026 09:00 ET | Source: PharmAla Biotech

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders

Pharmala announces a newly signed contract to supply a clinical trial, and the fulfillment of a previously announced trial.